Join us at the Future of Inhalation Drug Delivery Conference to learn about next-gen MDI development

Written By PY

Meet with CEO Prof Paul Young at this year’s “Future of Inhalation Drug Delivery Conference” to be held in Parma, Italy, from the 11th-13th September 2024. Learn how Ab Initio can provide GMP MDI manufacture for first in human and early phase trials and how through its partnership with OZUK’s MDI development services can provide you with rapid development of next-gen MDIs from bench to pilot scale. We look forward to seeing you there!

PY
Previous

Join US at the “Future of Inhalation Drug Delivery” Conference in Parma to learn about non-clinical tests for inhalation product evaluation
Next

Ab Initio Pharma Announces Sponsorship of the 2024 NSW Drug Discovery Forum Commercialisation Award